Product
IMCY-0098
Aliases
Imotope
1 clinical trial
2 indications
Indication
Diabetes MellitusIndication
Type 1Clinical trial
A Phase IIa, Randomized, Double-blind, Dose Comparison, Placebo-controlled, Multi-centre Clinical Trial to Evaluate the Immune Signature of the Treatment With the Imotope IMCY-0098 and Its Effect on the Preservation of Beta-cell Function in Adult Patients With a Recent Onset Type 1 DiabetesStatus: Active (not recruiting), Estimated PCD: 2025-01-01